Transcatheter Pulmonary Valve Market
Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report by Technology (Balloon-Expanded Transcatheter Valve, and Self-Expanded Transcatheter Valve), and by Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, and Others), Forecast Period (2023-2030)
Transcatheter pulmonary valve market is anticipated to grow at a CAGR of 7.3% during the forecast period (2023-2030). Pivotal factors attributed to market growth including increasing prevalence of various cardiovascular diseases (CVDs) such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases. The growing population with heart valve disorders and surging demand for pulmonary valve replacement are major factors supporting the market growth. According to the World Health Organization (WHO), an estimated 17.9 million people were deceased from CVDs in 2019, representing 32% of all global mortalities. Rheumatic heart disease and claims over 288,348 lives each year the large majority in low- or middle-income countries. An estimated 1.28 billion adults aged 30 to 79 years globally have hypertension, among which around two-thirds living in low and middle-income countries. In addition, an estimated 46% of adults with hypertension are unaware that they have the condition.
Segmental Outlook
The global transcatheter pulmonary valve market is segmented on the technology, and application. Based on the technology, the market is sub-segmented into balloon-expanded transcatheter valve and self-expanded transcatheter valve. Further, based on application, the market is sub-segmented into cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, and others. Where, others include tetralogy of fallot, truncusarteriosus. Among the application, the pulmonary stenosis sub-segment is anticipated to hold a considerable share of the market, owing to its enhanced feasibility of treating both aortic stenosis and aortic regurgitation with low rates of procedural complications.
The Balloon-Expanded Transcatheter Valve Sub-Segment is Anticipated to Hold a Considerable Share of the Global Transcatheter Pulmonary Valve Market
Among the products, balloon-expanded transcatheter valve sub-segment is expected to grow over the forecast period. The segmental growth is attributed to the increasing adoption rate for balloon-expanded transcatheter valve and the growing number of product development, and technical advancement. Thus, manufacturers are attracted towards manufacturing balloon-expanded technology which in turn is propelling the market growth. According to the article published by Elsevier JACC: Asia journal, on behalf of The American College of Cardiology Foundation, in September 2021, new-generation balloon-expandable valve (BEV) appeared to be a valid alternative to surgery, especially in some Asian countries with a higher prevalence of bicuspid aortic valve. Versatile techniques applied to BEV could treat anomaly, heavily calcified, larger annular BAVs safely, which were considered ineligible in TAVR due to high risk of Periventricular leukomalacia (PVL), coronary artery obstruction, Proton pump inhibitors (PPIs), and aortic rupture.
Regional Outlook
The global transcatheter pulmonary valve market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow over the forecast period, owing to the growing demand for innovative heart valves, increasing geriatric population, and rising healthcare expenditure.
Global Transcatheter Pulmonary Valve Market Growth, by Region 2023-2030
The North America Region is Expected to Grow at a Significant CAGR in the Global Transcatheter Pulmonary Valve Market
North America is expected to hold a prominent share in the transcatheter pulmonary valve market, owing to the presence of a well-developed healthcare sector, along with the rising prevalence of disorders such as pulmonary stenosis and regurgitation. Additionally, rising awareness and increasing demand for innovative heart valves, along with the rising healthcare expenditure are some other factors projected to drive the market growth over the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country.
As per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is expected to average 5.1% over 2021-2030, and will reach nearly $6.8 trillion by 2030. Growth in the nation’s GDP is also projected to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the healthcare share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing healthcare spending in the country is anticipated to push company activities and government initiatives in developing efficient transcatheter pulmonary valves, in turn bolstering the market growth.
Market Players Outlook
The major companies serving the global transcatheter pulmonary valve market include Boston Scientific Corp., Braile Biomedica, Medtronic PLC, Edwards Lifesciences Corp., Artivion, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Medtronic PLC relaunched first-of-its-kind transcatheter pulmonary valve replacement system for treating congenital heart disease.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global transcatheter pulmonary valve market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Boston Scientific Corp.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Braile Biomedica
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Medtronic PLC
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Edwards Lifesciences Corp.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
4. Market Segmentation
4.1. Global Transcatheter Pulmonary Valve Market by Technology
4.1.1. Balloon-Expanded Transcatheter Valve
4.1.2. Self-Expanded Transcatheter Valve
4.2. Global Transcatheter Pulmonary Valve Market by Application
4.2.1. Cardiac Anomaly
4.2.2. Pulmonary Atresia
4.2.3. Pulmonary Stenosis
4.2.4. Pulmonary Regurgitation
4.2.5. Others (Tetralogy of Fallot, Truncus Arteriosus)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 4C Medical Technologies, Inc.,
6.2. Abott laboratories
6.3. Artivion, Inc.
6.4. Colibri Heart Valve, LLC
6.5. Cryolife, Inc.
6.6. Direct Flow Medical, Inc.
6.7. JenaValve Technology, Inc.
6.8. Jude Medical Inc.
6.9. Labcor Laborateries Ltd.
6.10. Lepu Medical Technology (Beijing) Co., Ltd.
6.11. LivaNova PLC
6.12. St. Jude Medical, Inc.
6.13. SYMETIS SA
6.14. Venus Medtech (Hangzhou) Inc.
6.15. Xeltis B.V.
1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
12. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
13. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
14. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
15. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
16. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
17. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
18. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
20. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
21. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
22. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY MATERIAL, 2022 VS 2030 (%)
3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET SHARE BY REGION, 2022 VS 2030 (%)
6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. US TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
12. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
13. UK TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
14. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
15. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
16. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
17. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
18. REST OF EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
19. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
20. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
21. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
22. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
23. REST OF ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
24. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
